TR EN AR RU KK

429ATekscend Photomask Corp.

Teknoloji
🇯🇵 Japonya Borsası
3160.00
JPY
Analysis Scores
Lothien Robustness Score?
67/100
Strong
Neden bu skor?
Damodaran ?
54/100
Dalio Risk ?
98/100
Piotroski ?
0/9
Weak
Previous period ROA data missing (C1 delta-ROA); Total assets data missing → ROA cannot be calculated (C2); Operating cash flow data missing (C3, C4); Önceki yıl borç/varlık verisi yok → kaldıraç azalması kontrol edilemedi (C5); Current period current ratio missing (C6); current assets data missing → turnover calculation unavailable (C9)
Graham ?
Veri Yetersiz
Özkaynaklar negatif veya sıfır — Graham formülü pozitif defter değeri gerektirir
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
57/100
Lothien Sağlamlık: Orta (57/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumsuz | Uzun Vade: Nötr | Pozitif: 2 | Negatif: 0 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte ¥5.3B net kâr açıklandı. Şirket kârlı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%-15.8). İstikrarlı seyir.
Makul F/K
Trailing F/K: 13.0. Makul değerleme aralığında.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+36.8 artabilir (¥5.3B → ¥7.2B).

Data date 2026-10-30 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Method How the scores are computed · Scorecard
Data date 2026-10-30
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
252 days
Annual Volatility ?
%67.3
VaR 95% ?
%6.92
daily max loss
VaR 99% ?
%9.81
daily max loss
CVaR 95% ?
%8.86
expected loss (tail)
Max Drawdown ?
%41.3
11.05.2026 → 26.10.2026
Skewness ?
0.47
Parametrik%6.92
Historik%6.66
Cornish-Fisher%6.13
Return Distribution
Valuation
Potential?
+13.7%
ROIC ?
16.5%
DCF Value ?
2,265.52
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Net kâr çeyreklik %-15.8 düşerek 5.3B JPY oldu
Yıllık net kâr büyümesi sınırlı (%-3.2)
Ödenmiş sermaye: 99.3M JPY
Son 8 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-14.5 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 3696.98 JPY
Fundamental & Technical Analysis
Profitability
ROE - Return on Equity (TTM) %14.2
ROE %14.2 — moderate return on equity.
Free Cash Flow Margin (TTM) %-5.3
TTM Free Cash Flow is %-5.3'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 13.0x Sector: 20.8x
F/K 13.0x — sector median's (20.8x) %38 below. Attractive for value investing.
P/B Ratio 1.85x Sector: 2.52x
PD/DD 1.85x — sector median (2.52x) below or near. Reasonable valuation.
EV/EBITDA 7.7x Sector: 10.4x
EV/EBITDA 7.7x — sector median (10.4x) in line.
Indebtedness
Current Ratio 2.82x
Current ratio 2.82x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 0.0x
Net Debt/EBITDA 0.0x — very low debt burden. Company can repay debt quickly.
Debt / Equity 0.01x
Low leverage — majority of assets financed by equity.
Interest Coverage 54.9x
Interest coverage 54.9x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+14.9
Revenue YoY %14.9 grew — healthy growth rate.
Net Profit Growth (YoY) %-3.2
Net profit YoY %-3.2 declined — profitability under pressure.
Seasonality Analysis Q3 (Tem-Eyl)
Historically strongest quarter: Q3 (Jul-Sep) (avg. profit 4.7B). Weakest quarter: Q1 (Jan-Mar) (avg. profit 4.3B).
Score Explanations
Lothien Robustness
67/100
Good robustness (67/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+13.7%
Plus %13.7 expected value (3690.34) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 5273.22 | P/B target: 4612.31 | EV/EBITDA target: 4371.37 | DCF target: 2265.52
Damodaran Valuation
54/100
Moderate Damodaran score (54/100). ROIC (%16.5) – WACC (%9.7) difference +6.8 bps. Value creation capacity limited.
Moderate
Dalio Risk Analysis
98/100
Low debt risk (98/100). Interest coverage ratio 54.9x — strong. Debt/EBITDA 0.0x — in healthy range.
Leverage: 99/100 | Debt Service: 100/100 | Quality: 89/100
ROIC - Return on Capital
%16.5
ROIC (%16.5) cost of capital 6.8 bps above → company creates value.
WACC: %9.7
DCF Discounted Cash Flow
2,265.52
DCF (2265.52) current price %30.2 below — cash flows do not support current price.
Current price: 3245.00
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
0/9
Weak Piotroski (0/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Total assets data missing → ROA cannot be calculated (C2)
Weak
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
13.0x vs 20.8x
Sector median's %38 below — cheap
P/B Ratio
1.85x vs 2.52x
Compared to sector %27 cheaper (by book value)
EV/EBITDA
7.7x vs 10.4x
Compared to sector %26 lower EV/EBITDA
ROIC vs WACC
%16.5 vs %9.7 WACC
ROIC 6.8 bps above cost of capital
Net Profit Margin (TTM)
%19.3 vs %27.2 EBITDA margin
TTM net profit margin %19.3
TRAMA-99 Trend — Downtrend
Price (3160.00), TRAMA-99 line's %14.5 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 3160.00
TRAMA: 3696.98
Difference: %-14.5
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
429A — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.